Revance Therapeutics Inc (NASDAQ:RVNC) shares, rose in value, with the stock price down by -2.46% to the previous day’s close as strong demand from buyers drove the stock to $3.57.
Actively observing the price movement in the last trading, the stock closed the session at $3.66. Referring to stock’s 52-week performance, its high was $37.98, and the low was $3.61. On the whole, RVNC has fluctuated by -23.23% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RVNC’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of RVNC currently trading nearly -16.69% and -30.35% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 27.36, while the 7-day volatility ratio is showing 5.62% which for the 30-day chart, stands at 5.90%. Furthermore, Revance Therapeutics Inc (RVNC)’s beta value is 1.15, and its average true range (ATR) is 0.29.
A comparison of Revance Therapeutics Inc (RVNC) with its peers suggests the former has fared considerably weaker in the market. RVNC showed an intraday change of -2.46% in last session, and over the past year, it shrunk by -88.67%%.
Data on historical trading for Revance Therapeutics Inc (NASDAQ:RVNC) indicates that the trading volumes over the past 3 months, they’ve averaged 1.79 million. According to company’s latest data on outstanding shares, there are 104.22 million shares outstanding.
Nearly 8.63% of Revance Therapeutics Inc’s shares belong to company insiders and institutional investors own 75.47% of the company’s shares. The stock has fallen by -59.39% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RVNC stock heading into the next quarter.
